Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.


TSXV:CVM.H - Post by User

Bullboard Posts
Comment by Nastroon Feb 28, 2019 2:39pm
71 Views
Post# 29424519

RE:Page 28

RE:Page 28That's a very good point Growth I've thought about it a lot myself as to why it's not got a much bigger market cap.  The main reasons I can come up with are:
  • It's on the wrong exchange.  Should be on NASDAQ, many US investors don't like the TSX-V and the OTC.  
  • Its a 'one trick pony' as it's  only got one product
  • This is their first product bought to market so they have no previous track record of success.
  • It has not yet had FDA approval and therefore if it fails there's nothing else out there so many will wait until it's cleared this hurdle.
  • its very small and therefore too illiquid for many and just too far below the radar for most.
For what it's worth I can't see it not getting FDA approval and I fully expect it to sell very well.  However, the risk is primarily in the sales and marketing in my opinion.  When I ran a comparison between CVR and Helius I had it coming out at between 12 to 15 times the size in market cap terms.  Still only time will tell on that and as I said all in my opinion.

Bullboard Posts